Multidiagnostic platform for Alzheimer’s disease

Development of a multi-diagnostic platform combining extraction, immunoassay and real-time PCR.

 

Combination of an enrichment process for diagnostically relevant biomarkers in blood samples from patients.

 

Improvement of the detection limit of immunological test methods for Alzheimer's related biomarkers. 

Joint Project

Roboscreen GmbH, Imk Health Intelligence GmbH and EDC Engineering GmbH develop and evaluatea multidiagnostic platform combining enrichment methods as well as improvement of biomarker detection and quantification of Alzheimer's related biomarkers in blood/serum/plasma and urine.

Funded Project

Funded Project No. 100690291

Timeline

Started in October 2023.

This site uses cookies

This site uses cookies. These have two functions: First, they provide basic functionality for this website. Second, they enable us to improve our content for you by storing and analyzing anonymous user data. You can withdraw your consent to the use of these cookies at any time. More information about cookies can be found in our privacy policy.

More information
+
Essential

Essential cookies are required for basic functions of the website. This ensures that the website functions properly.

Name QiCookieConsent
Provider QiTEC GmbH
Purpose Contains the cookie groups approved by the user and checks them when the page is accessed.
Lifetime 1 year